Mode of action in relevance of rodent liver tumors to human cancer risk

Michael P. Holsapple, Henri C. Pitot, Samuel Monroe Cohen, Alan R. Boobis, James E. Klaunig, Timothy Pastoor, Vicki L. Dellarco, Yvonne P. Dragan

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

Hazard identification and risk assessment paradigms depend on the presumption of the similarity of rodents to humans, yet species specific responses, and the extrapolation of high-dose effects to low-dose exposures can affect the estimation of human risk from rodent data. As a consequence, a human relevance framework concept was developed by the International Programme on Chemical Safety (IPCS) and International Life Sciences Institute (ILSI) Risk Science Institute (RSI) with the central tenet being the identification of a mode of action (MOA). To perform a MOA analysis, the key biochemical, cellular, and molecular events need to first be established, and the temporal and dose-dependent concordance of each of the key events in the MOA can then be determined. The key events can be used to bridge species and dose for a given MOA. The next step in the MOA analysis is the assessment of biological plausibility for determining the relevance of the specified MOA in an animal model for human cancer risk based on kinetic and dynamic parameters. Using the framework approach, a MOA in animals could not be defined for metal overload. The MOA for phenobarbital (PB)-like P450 inducers was determined to be unlikely in humans after kinetic and dynamic factors were considered. In contrast, after these factors were considered with reference to estrogen, the conclusion was drawn that estrogen-induced tumors were plausible in humans. Finally, it was concluded that the induction of rodent liver tumors by porphyrogenic compounds followed a cytotoxic MOA, and that liver tumors formed as a result of sustained cytotoxicity and regenerative proliferation are considered relevant for evaluating human cancer risk if appropriate metabolism occurs in the animal models and in humans.

Original languageEnglish (US)
Pages (from-to)51-56
Number of pages6
JournalToxicological Sciences
Volume89
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Liver
Tumors
Rodentia
Animals
Neoplasms
Estrogens
Kinetics
Cytotoxicity
Phenobarbital
Extrapolation
Metabolism
Risk assessment
Hazards
Animal Models
Metals
Chemical Safety
Biological Science Disciplines

ASJC Scopus subject areas

  • Toxicology

Cite this

Holsapple, M. P., Pitot, H. C., Cohen, S. M., Boobis, A. R., Klaunig, J. E., Pastoor, T., ... Dragan, Y. P. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicological Sciences, 89(1), 51-56. https://doi.org/10.1093/toxsci/kfj001

Mode of action in relevance of rodent liver tumors to human cancer risk. / Holsapple, Michael P.; Pitot, Henri C.; Cohen, Samuel Monroe; Boobis, Alan R.; Klaunig, James E.; Pastoor, Timothy; Dellarco, Vicki L.; Dragan, Yvonne P.

In: Toxicological Sciences, Vol. 89, No. 1, 01.01.2006, p. 51-56.

Research output: Contribution to journalArticle

Holsapple, MP, Pitot, HC, Cohen, SM, Boobis, AR, Klaunig, JE, Pastoor, T, Dellarco, VL & Dragan, YP 2006, 'Mode of action in relevance of rodent liver tumors to human cancer risk', Toxicological Sciences, vol. 89, no. 1, pp. 51-56. https://doi.org/10.1093/toxsci/kfj001
Holsapple, Michael P. ; Pitot, Henri C. ; Cohen, Samuel Monroe ; Boobis, Alan R. ; Klaunig, James E. ; Pastoor, Timothy ; Dellarco, Vicki L. ; Dragan, Yvonne P. / Mode of action in relevance of rodent liver tumors to human cancer risk. In: Toxicological Sciences. 2006 ; Vol. 89, No. 1. pp. 51-56.
@article{d6d27a8c7bda447da6d99bc29bcf5385,
title = "Mode of action in relevance of rodent liver tumors to human cancer risk",
abstract = "Hazard identification and risk assessment paradigms depend on the presumption of the similarity of rodents to humans, yet species specific responses, and the extrapolation of high-dose effects to low-dose exposures can affect the estimation of human risk from rodent data. As a consequence, a human relevance framework concept was developed by the International Programme on Chemical Safety (IPCS) and International Life Sciences Institute (ILSI) Risk Science Institute (RSI) with the central tenet being the identification of a mode of action (MOA). To perform a MOA analysis, the key biochemical, cellular, and molecular events need to first be established, and the temporal and dose-dependent concordance of each of the key events in the MOA can then be determined. The key events can be used to bridge species and dose for a given MOA. The next step in the MOA analysis is the assessment of biological plausibility for determining the relevance of the specified MOA in an animal model for human cancer risk based on kinetic and dynamic parameters. Using the framework approach, a MOA in animals could not be defined for metal overload. The MOA for phenobarbital (PB)-like P450 inducers was determined to be unlikely in humans after kinetic and dynamic factors were considered. In contrast, after these factors were considered with reference to estrogen, the conclusion was drawn that estrogen-induced tumors were plausible in humans. Finally, it was concluded that the induction of rodent liver tumors by porphyrogenic compounds followed a cytotoxic MOA, and that liver tumors formed as a result of sustained cytotoxicity and regenerative proliferation are considered relevant for evaluating human cancer risk if appropriate metabolism occurs in the animal models and in humans.",
author = "Holsapple, {Michael P.} and Pitot, {Henri C.} and Cohen, {Samuel Monroe} and Boobis, {Alan R.} and Klaunig, {James E.} and Timothy Pastoor and Dellarco, {Vicki L.} and Dragan, {Yvonne P.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1093/toxsci/kfj001",
language = "English (US)",
volume = "89",
pages = "51--56",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Mode of action in relevance of rodent liver tumors to human cancer risk

AU - Holsapple, Michael P.

AU - Pitot, Henri C.

AU - Cohen, Samuel Monroe

AU - Boobis, Alan R.

AU - Klaunig, James E.

AU - Pastoor, Timothy

AU - Dellarco, Vicki L.

AU - Dragan, Yvonne P.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Hazard identification and risk assessment paradigms depend on the presumption of the similarity of rodents to humans, yet species specific responses, and the extrapolation of high-dose effects to low-dose exposures can affect the estimation of human risk from rodent data. As a consequence, a human relevance framework concept was developed by the International Programme on Chemical Safety (IPCS) and International Life Sciences Institute (ILSI) Risk Science Institute (RSI) with the central tenet being the identification of a mode of action (MOA). To perform a MOA analysis, the key biochemical, cellular, and molecular events need to first be established, and the temporal and dose-dependent concordance of each of the key events in the MOA can then be determined. The key events can be used to bridge species and dose for a given MOA. The next step in the MOA analysis is the assessment of biological plausibility for determining the relevance of the specified MOA in an animal model for human cancer risk based on kinetic and dynamic parameters. Using the framework approach, a MOA in animals could not be defined for metal overload. The MOA for phenobarbital (PB)-like P450 inducers was determined to be unlikely in humans after kinetic and dynamic factors were considered. In contrast, after these factors were considered with reference to estrogen, the conclusion was drawn that estrogen-induced tumors were plausible in humans. Finally, it was concluded that the induction of rodent liver tumors by porphyrogenic compounds followed a cytotoxic MOA, and that liver tumors formed as a result of sustained cytotoxicity and regenerative proliferation are considered relevant for evaluating human cancer risk if appropriate metabolism occurs in the animal models and in humans.

AB - Hazard identification and risk assessment paradigms depend on the presumption of the similarity of rodents to humans, yet species specific responses, and the extrapolation of high-dose effects to low-dose exposures can affect the estimation of human risk from rodent data. As a consequence, a human relevance framework concept was developed by the International Programme on Chemical Safety (IPCS) and International Life Sciences Institute (ILSI) Risk Science Institute (RSI) with the central tenet being the identification of a mode of action (MOA). To perform a MOA analysis, the key biochemical, cellular, and molecular events need to first be established, and the temporal and dose-dependent concordance of each of the key events in the MOA can then be determined. The key events can be used to bridge species and dose for a given MOA. The next step in the MOA analysis is the assessment of biological plausibility for determining the relevance of the specified MOA in an animal model for human cancer risk based on kinetic and dynamic parameters. Using the framework approach, a MOA in animals could not be defined for metal overload. The MOA for phenobarbital (PB)-like P450 inducers was determined to be unlikely in humans after kinetic and dynamic factors were considered. In contrast, after these factors were considered with reference to estrogen, the conclusion was drawn that estrogen-induced tumors were plausible in humans. Finally, it was concluded that the induction of rodent liver tumors by porphyrogenic compounds followed a cytotoxic MOA, and that liver tumors formed as a result of sustained cytotoxicity and regenerative proliferation are considered relevant for evaluating human cancer risk if appropriate metabolism occurs in the animal models and in humans.

UR - http://www.scopus.com/inward/record.url?scp=29544450979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29544450979&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfj001

DO - 10.1093/toxsci/kfj001

M3 - Article

VL - 89

SP - 51

EP - 56

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -